Linear accelerators (LINAC) are prominently used in the medical industry for treating cancer patients. Cancer is the second major cause of death globally, and the disease has significant economic impact. In 2018, World Health Organization (WHO), through its cancer research agency named International Agency for Research on Cancer (IARC), had estimated that 18.1 million new cases and 9.6 million deaths have risen. Ageing and population growth, and changes in the economic and social factors causing certain causes of cancer are the key factors contributing to rising cancer burden. Moreover, most cancer cases are diagnosed at the last stage of it. Hence, as the incidence of cancer is increasing, the need for cost-efficient cancer care is growing, which in turn has led to significant investments on cutting-edge technologies to develop new treatment options around the world. Some of the major technologically advanced cancer centers in the world that are constantly developing advanced products and services for treating cancer patients include Macarthur Cancer Service (Australia), James Cancer Hospital and Solove Research Institute (US), VallD'Hebron Institute of Oncology (Spain), Townsville Cancer Centre (Australia), Apollo Hospitals, University of Chicago Medicine Comprehensive Cancer Center (US), Spanish National Cancer Research Center (Spain), Christie Hospital NHS Foundation Trust (UK), Princess Margaret Cancer Centre (Canada), Abramson Cancer Center (US), Netherlands Cancer Institute, and Hong Kong Adventist Oncology Center.
Accelerators play a significant role in modern healthcare. Medical linear accelerators use high-energy x-rays to destroy cancer cells and tumors while sparing adjacent normal tissues. LINAC are considered as innovative devices, which have revolutionized cancer treatment owing to their cost-effectiveness. Further, the market has observed a momentous shift in cancer treatment with growing preference shift from invasive to noninvasive treatment procedures. The noninvasive treatment comprises radiation therapy, which is the cost-effective and most advanced treatment option, and it can be applied to treat a wide range of cancers, either alone or in combination with chemotherapy, surgery, and other treatment procedures.
According to latest situation report from World Health Organization (WHO), the US, Spain, Italy, France, Germany, UK, Russia, Turkey, Brazil, Iran, and China are among the worst-affected countries due to COVID-19 outbreak. The outbreak first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. As per latest WHO figures for June 30, 2020, there are ~10.18 million confirmed COVID-19 cases globally with ~503,862 total deaths, and the number is growing at varying rates in different countries. The COVID-19 crisis is affecting the industries worldwide, and the global economy is anticipated to experience the worst hit in 2020, as well as in 2021. The outbreak has created significant disruptions in primary industries such as manufacturing, medical, energy & power, electronics & semiconductors, and automotive. The sharp decline in industrial activities is impacting the growth of global linear accelerator market as they are the major supply and demand points for the market players. The factory shutdowns, travel and trade bans, and border lockdowns to combat and contain the outbreak have impacted manufacturing, supply, and sales of various electronic components that are required for linear accelerator manufacturing.
The advent of artificial intelligence (AI) and machine learning (ML) is transforming the medical imaging device landscape globally, especially by adding to the effectiveness of cancer treatment through technologies such as LINAC. As a result, the market players are further focusing on the development of ML- and AI-enabled LINACs for oncology treatment. This technique is likely to be transformed into convenient treatment option in the near future. For instance, in 2019, Varian Medical Systems, Inc. launched its Ethos therapy, an AI-Powered Adaptive Radiotherapy Treatment system. It comprises a linear accelerator and is built to enhance capability, flexibility, and efficiency of radiotherapy. This new solution is developed to provide an online adaptive treatment in a 15-minute time slot, from patient setup through treatment delivery. Further, in 2018, Elekta Inc. and IBM Watson Health collaborated for digital solutions in cancer care. Thus, the integration of advanced technologies is expected to boost the acceptance of linear accelerators in the coming years.
Based on energy range, the linear accelerator market is segmented into less than 4 MeV, 4 MeV to 8 MeV, 8 MeV to 12 MeV, and more than 12 MeV. Companies such as Manoir Industries uses linac system, the Pîtres plant of the company has five radiographic rooms, which represents 9MeV energy range linear accelerator – cobalt-iridium.
Based on application, the linear accelerator market is segmented into industrial radiography, cargo screening, radiation processing, and others. In 2019, the radiation processing segment led the linear accelerator market in terms of size. The radiation processing includes stimulation of chemical reactions with ionizing radiations in different materials. It includes the modification of polymeric materials, sterilization of medical devices, treatment of waste, and preservation of food.
Based on industry, the linear accelerator market is segmented into automotive, aerospace and defense, medical, food and beverages, metals and mining, and others. The medical industry is a prominent user of linear accelerators for treating cancer patients. Companies such as Elekta, Varian, and Bevatech GmbH take advantage of the linear accelerator to treat patients.
The market players focus on new product innovations and developments by integrating advanced technologies and features in their products to compete with the competitors.
The regional trends and factors influencing the Linear Accelerator Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Linear Accelerator Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 3.79 Billion |
| Market Size by 2027 | US$ 6.8 Billion |
| Global CAGR (2019 - 2027) | 7.9% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Energy Range
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Linear Accelerator Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Linear Accelerator Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The List of companies - Linear Accelerator Market
The North America region led the linear accelerator market in 2019. The constant technological advancements have created a stir in the competitive market in the region, which is led by continuous investments by tech giants in R&D activities. This investment helps in making the region able to adapt technologies at an early phase. The countries such as the US spends heavily on advancing its healthcare industry to support the well-being and health of individuals. New technology is providing radiation oncologists at the MD Anderson Cancer Center- a real-time view of tumors. The technology used in this called MR-linac, which combines linear accelerator and high-strength magnetic resonance imaging (MRI) machine into a single device.
The medical is the leading industry in the market. The medical industry is a prominent user of a linear accelerator for treating cancer patients. It adapts high energy x-rays to destroy cancer cells and tumor's shape while sparing nearby normal tissue. Henceforth, quality assurance of a linear accelerator is a must as it heavily used to treat cancer in any area of a human body. This technology is further used to implement a variety of radiation delivery techniques such as- conventional external beam radiation therapy, intensity-modulated radiation therapy, image-guided radiation therapy, and stereotactic body radiation therapy.
The growth in the construction and expansion of airports is anticipated to boost the demand for linear accelerators. The significant contracts between government and market players as well as growing construction activities of new airports worldwide are propelling the growth of linear accelerator market.